Product quality of parenteral vancomycin products in the United States.

Nambiar, S; Madurawe, R D; Zuk, S M; Khan, S R; Ellison, C D; Faustino, P J; Mans, D J; Trehy, M L; Hadwiger, M E; Boyne, M T; Biswas, K; Cox, E M

Nambiar, S; Madurawe, R D; Zuk, S M; Khan, S R; Ellison, C D; Faustino, P J; Mans, D J; Trehy, M L; Hadwiger, M E; Boyne, M T; Biswas, K; Cox, E M.

Affiliation

Nambiar S; US Food and Drug Administration, Center for Drug Evaluation and Research, Office of Antimicrobial Products, Silver Spring, Maryland, USA. sumathi.nambiar@fda.hhs.gov

Antimicrob Agents Chemother ; 56(6): 2819-23, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22314525

Subject(s)

Vancomycin; Consumer Product Safety; United States; United States Food and Drug Administration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin Type of study: Prognostic_studies Country/Region as subject: America do norte Language: En Journal: Antimicrob Agents Chemother Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google